The aim of our study was to present our experience with the use of peripherally inserted central catheters (PICCs) in pediatric patients receiving autologous or allogenic blood stem-cell transplantation. The insertion of the device in older children does not require general anesthesia and does not require a surgical procedure.
Methods:
From January 2014 to January 2017, 13 PICCs were inserted as a central venous device in 11 pediatric patients submitted to 14 autologous or allogeneic stem-cell transplantation, at the Bone Marrow Transplant Unit of the Children’s Hospital of Brescia. The mean age of patients at the time of the procedure was 11.3 years (range 3-18 years). PICCs remained in place for an overall period of 4104 days. All PICCs were positioned by the same specifically trained physician and utilized by nurses of our stem-cell transplant unit.
Results:
No insertion-related complications were observed. Late complications were catheter ruptures and line occlusions (1.2 per 1000 PICC days). No rupture or occlusion required removal of the device. No catheter-related venous thrombosis, catheter-related bloodstream infection (CRBSI), accidental removal or permanent lumen occlusion were observed. Indications for catheter removal were completion of therapy (8 patients) and death (2 patients). Three PICCs are currently being used for blood sampling in follow-up patients after transplantation.
Conclusions:
Our data suggest that PICCs are a safe and effective alternative to conventional central venous catheters even in pediatric patients with high risk of infectious and hemorrhagic complications such as patients receiving stem-cell transplantation.
PalmerJMcCuneJSPeralesMA. Personalizing busulfan-based conditioning: considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee. Biol Blood Marrow Transplant. 2016;22(11):1915-1925.
3.
BaroneALucarelliAOnofrilloD. Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association; Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP). Diagnosis and management of acquired aplastic anemia in childhood. Blood Cells Mol Dis. 2015;55(1):40-47.
4.
VidalVMullerCJacquierA. Évaluation prospective des complications des PICCs. J Radiol. 2008;89(4):495-498.
5.
KangJChenWSunW. Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days. J Vasc Access. 2017;18(2):153-157.
6.
ParkKJunHJOhSY. Safety, efficacy, and patient-perceived satisfaction of peripherally inserted central catheters in terminally ill cancer patients: a prospective multicenter observational study. Support Care Cancer. 2016;24(12):4987-4992.
7.
MolleePJonesMStackelrothJ. Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study. J Hosp Infect. 2011;78(1):26-30.
8.
CotogniPPittirutiM. Focus on peripherally inserted central catheters in critically ill patients. World J Crit Care Med. 2014;3(4):80-94.
CotogniPBarberoCGarrinoC. Peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study. Support Care Cancer. 2015;23(2):403-409.
11.
BaudinGOccelliABoyerCGeoffrayAChevallierP. Évaluation des cathéters centraux à insertion périphérique en population pédiatrique. Arch Pediatr. 2013;20(10):1089-1095.
12.
MatsuzakiASuminoeAKogaYHatanoMHattoriSHaraT. Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer. 2006;14(2):153-160.
13.
HatakeyamaNHoriTYamamotoM. An evaluation of peripherally inserted central venous catheters for children with cancer requiring long-term venous access. Int J Hematol. 2011;94(4):372-377.
14.
FadooZNisarMIIftikharRAliSMushtaqNSayaniR. Peripherally inserted central venous catheters in pediatric hematology/oncology patients in tertiary care setting: a developing country experience. J Pediatr Hematol Oncol. 2015;37(7):e421-e423.
15.
OGradyNPAlexanderMDellingerEP. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep. 2002;51(RR-10):1-29.
16.
LovedayHPWilsonJAPrattRJ. UK Department of Health.epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2014;86(Suppl 1):S1-S70.
Bodenham ChairABabuSBennettJ. Association of Anaesthetists of Great Britain and Ireland: safe vascular access 2016. Anaesthesia2016;71(5):573-585.
20.
MermelLAAllonMBouzaE. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45. Erratum in Clin Infect Dis. 2010;50(7):1079. (Dosage error in article text).
21.
ManianFA. IDSA guidelines for the diagnosis and management of intravascular catheter-related bloodstream infection. Clin Infect Dis. 2009;49(11):1770-1; author reply 1771-2.
22.
MermelLAFarrBMSherertzRJ. Infectious Diseases Society of America, American College of Critical Care Medicine, Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs. 2001;24(3):180-205.
23.
FischmeisterGWittVZaunschirmHA. Permanent tunneled silicone central venous catheters for autologous PBPC harvest in children and young adults. Bone Marrow Transplant. 2000;26(7):781-786.
24.
CarraroFCicaleseMPCesaroS. Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP). Ann Hematol. 2013;92(10):1405-1412.
25.
AbedinSKapoorG. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008;51(2):251-255.
26.
WalsheLJMalakSFEaganJSepkowitzKA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002;20(15):3276-3281.
27.
YapYSKarapetisCLeroseSIyerSKoczwaraB. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care (Engl). 2006;15(4):342-347.
28.
WorthLJSeymourJFSlavinMA. Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices. Support Care Cancer. 2009;17(7):811-818.
29.
HarterCOstendorfTBachAEgererGGoldschmidtHHoAD. Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies. Support Care Cancer. 2003;11(12):790-794.
30.
MakiDGKlugerDMCrnichCJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81(9):1159-1171.
31.
BellesiSChiusoloPDe PascaleG. Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation. Support Care Cancer. 2013;21(2):531-535.
32.
UderzoCD’AngeloPRizzariC. Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies. Bone Marrow Transplant. 1992;9(2):113-117.
33.
PektaşAKaraAGurgeyA. Cohort study: central venous catheter-related complications in children with hematologic diseases at a single center. Turk J Haematol. 2015;32(2):144-151.
